|
|
|
|
||
Re: Bank of America on Sanofi cash deploymentYou quoted only the first part of the tweet. Sanofi's hemo A/B lentiviral program with San Raffaele is where the "lack of optimism" lays. Cash likely reallocated into R&D focussed bolt-on M&A in oncology, immunology and gene-therapy Management has also expressed a lack of optimism for third-party first-wave haemophilia gene-therapy projects vs its earlier-stage in-house lentiviral tech. |
return to message board, top of board |